David Eveleth

938 total citations
27 papers, 800 citations indexed

About

David Eveleth is a scholar working on Molecular Biology, Cell Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, David Eveleth has authored 27 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Cell Biology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in David Eveleth's work include Corneal Surgery and Treatments (7 papers), Corneal surgery and disorders (5 papers) and Nerve injury and regeneration (4 papers). David Eveleth is often cited by papers focused on Corneal Surgery and Treatments (7 papers), Corneal surgery and disorders (5 papers) and Nerve injury and regeneration (4 papers). David Eveleth collaborates with scholars based in United States, Ireland and United Kingdom. David Eveleth's co-authors include Joan Marsh, Raymond T. Bartus, Ralph Bradshaw, James C. Powers, Zhaozhao Li, Jennifer E. Foreman, Reginald L. Dean, Gary Lynch, Morton E. Weichsel and Steven Mennerick and has published in prestigious journals such as Nucleic Acids Research, Neuron and Brain Research.

In The Last Decade

David Eveleth

27 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Eveleth United States 14 430 231 205 103 79 27 800
Véronique Planchamp Germany 7 369 0.9× 283 1.2× 66 0.3× 71 0.7× 85 1.1× 7 731
Paul Diaz United States 12 362 0.8× 192 0.8× 80 0.4× 34 0.3× 64 0.8× 17 775
Simone Diestel Germany 15 424 1.0× 164 0.7× 117 0.6× 40 0.4× 38 0.5× 21 652
Alessio Cardinale Italy 22 689 1.6× 175 0.8× 75 0.4× 31 0.3× 91 1.2× 34 1.1k
A. Joseph Bloom United States 18 562 1.3× 141 0.6× 126 0.6× 46 0.4× 42 0.5× 29 1.1k
Krishna Baksi Puerto Rico 11 328 0.8× 146 0.6× 76 0.4× 51 0.5× 59 0.7× 30 514
Pablo H.H. López Argentina 17 314 0.7× 323 1.4× 88 0.4× 41 0.4× 44 0.6× 35 854
Roman Meyer Germany 9 511 1.2× 221 1.0× 37 0.2× 65 0.6× 162 2.1× 10 934
Mitsuyoshi Azuma United States 27 1.1k 2.7× 266 1.2× 790 3.9× 28 0.3× 94 1.2× 71 1.7k
Boonlert Cheewatrakoolpong United States 12 297 0.7× 91 0.4× 64 0.3× 61 0.6× 56 0.7× 20 732

Countries citing papers authored by David Eveleth

Since Specialization
Citations

This map shows the geographic impact of David Eveleth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Eveleth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Eveleth more than expected).

Fields of papers citing papers by David Eveleth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Eveleth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Eveleth. The network helps show where David Eveleth may publish in the future.

Co-authorship network of co-authors of David Eveleth

This figure shows the co-authorship network connecting the top 25 collaborators of David Eveleth. A scholar is included among the top collaborators of David Eveleth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Eveleth. David Eveleth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rowe-Rendleman, Cheryl L., David Eveleth, Jeffrey L. Goldberg, et al.. (2023). Development of Anterior Segment Focused Biologic Therapies to Regenerate Corneal Tissue for the Treatment of Disease: Drug Development Experience. Journal of Ocular Pharmacology and Therapeutics. 39(8). 551–562. 1 indexed citations
2.
3.
Bernatchez, Pascal, Bo Tao, Ralph Bradshaw, David Eveleth, & William C. Sessa. (2021). Characterization of a Novel Caveolin Modulator That Reduces Vascular Permeability and Ocular Inflammation. Translational Vision Science & Technology. 10(6). 21–21. 5 indexed citations
4.
Eveleth, David, et al.. (2020). Proliferation of Human Corneal Endothelia in Organ Culture Stimulated by Wounding and the Engineered Human Fibroblast Growth Factor 1 Derivative TTHX1114. Journal of Ocular Pharmacology and Therapeutics. 36(9). 686–696. 13 indexed citations
5.
Eveleth, David. (2013). Cell-Based Therapies for Ocular Disease. Journal of Ocular Pharmacology and Therapeutics. 29(10). 844–854. 10 indexed citations
6.
7.
Bosworth, Charles, et al.. (2009). Efficacy and Safety of PF-03187207, A Novel Nitric Oxide Donating Prostaglandin F2-Alpha Analogue, vs. Latanoprost in Hypertensive Eyes. Investigative Ophthalmology & Visual Science. 50(13). 2481–2481. 3 indexed citations
8.
Bartus, Raymond T., Reginald L. Dean, Steven Mennerick, David Eveleth, & Gary Lynch. (1998). Temporal ordering of pathogenic events following transient global ischemia. Brain Research. 790(1-2). 1–13. 48 indexed citations
9.
Caner, Hakan H., Frank Schottler, Aij‐Lie Kwan, et al.. (1997). Attenuation of vasospasm and hemoglobin-induced constriction in the rabbit basilar artery by a novel protease inhibitor. Neurosurgical FOCUS. 3(4). E4–E4. 3 indexed citations
10.
Yao, Hiroshi, Myron D. Ginsberg, David Eveleth, et al.. (1995). Local Cerebral Glucose Utilization and Cytoskeletal Proteolysis as Indices of Evolving Focal Ischemic Injury in Core and Penumbra. Journal of Cerebral Blood Flow & Metabolism. 15(3). 398–408. 58 indexed citations
11.
Pettit, Hugh O., David Lutz, Carlos Enrique Gutierrez, & David Eveleth. (1994). I.c.v. infusions of ACPD(1S,3R) attenuate learning in a Morris water maze paradigm. Neuroscience Letters. 178(1). 43–46. 21 indexed citations
12.
Li, Zhaozhao, Hitoshi Hori, Kourosch Abbaspour Tehrani, et al.. (1993). Peptide .alpha.-keto ester, .alpha.-keto amide, and .alpha.-keto acid inhibitors of calpains and other cysteine proteases. Journal of Medicinal Chemistry. 36(22). 3472–3480. 89 indexed citations
13.
Jacobson, Kenneth A., Olga Nikodijević, Deborah A. Berkich, et al.. (1992). Synthesis and biological activity of N6-(p-sulfophenyl)alkyl and N6-sulfoalkyl derivatives of adenosine: water-soluble and peripherally selective adenosine agonists.. Journal of Medicinal Chemistry. 35(22). 4143–4149. 39 indexed citations
14.
Bradshaw, Ralph, Joseph G. Altin, Michael Blaber, et al.. (1990). Chapter 13 Neurotrophic factors in the CNS: biosynthetic processing and functional responses. Progress in brain research. 86. 157–167. 5 indexed citations
15.
Schwarz, Martin A., Patricia J. Brown, David Eveleth, & Ralph Bradshaw. (1989). Modulation of growth factor induced fiber outgrowth in rat pheochromocytoma (PC12) cells by a fibronectin receptor antibody. Journal of Cellular Physiology. 138(1). 121–128. 13 indexed citations
16.
17.
Eveleth, David. (1988). Nerve growth factor receptors: Structure and function. In Vitro Cellular & Developmental Biology - Plant. 24(12). 1148–1153. 13 indexed citations
18.
Eveleth, David & Joan Marsh. (1987). Overlapping transcription units in Drosophila: Sequence and structure of the Cs gene. Molecular and General Genetics MGG. 209(2). 290–298. 8 indexed citations
19.
Eveleth, David & Joan Marsh. (1986). Sequence and expression of theCcgene, a member of the dopa decarboxylase gene cluster ofDrosophila: possible translational regulation. Nucleic Acids Research. 14(15). 6169–6183. 69 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Véronique Planchamp Breakdown of academic impact, for papers by Paul Diaz Breakdown of academic impact, for papers by Simone Diestel Breakdown of academic impact, for papers by Alessio Cardinale Breakdown of academic impact, for papers by A. Joseph Bloom Breakdown of academic impact, for papers by Krishna Baksi Breakdown of academic impact, for papers by Pablo H.H. López Breakdown of academic impact, for papers by Roman Meyer Breakdown of academic impact, for papers by Mitsuyoshi Azuma Breakdown of academic impact, for papers by Boonlert Cheewatrakoolpong
Rankless by CCL
2026